ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Integrity CE

V. Lee, R. Kumar, N. Bhagat, E. Winslow

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Integrity CE

V. Lee, E. Christenson, N. Bhagat, E. Winslow

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary Cancer…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, K. Spencer, M. Cecchini

Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions

Arndt Vogel

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highlights"

Insights from 2023 ESMO Annual Meeting

L. Rimassa

Hepatic Arterial Infusion for Primary Liver Cancer

Integrity CE

K. Lafaro

Updates in Targeted Therapies for Metastatic Biliary Tract Cancers

Integrity CE

J. Harding

ESMO Asia 2023 Insights: "Past, Present & Future Clinical Management…

Insights from 2023 ESMO Asia Annual Meeting

M. Ikeda

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor Infig…

Insights from 2024 ASCO® GI Annual Meeting

G. Abou-Alfa

How to Incorporate Molecular Testing in Therapy for Localized Cholan…

Flavio Rocha

ASCO® 2024 Summary: "Highlights in Biliary Tract Cancer"

2024 ASCO® Annual Meeting Insights Hub

A. Vogel

Great Debate: Neoadjuvant vs. Adjuvant Therapy for High-Risk BTC - P…

2023 Johns Hopkins Updates in Gastrointestinal Cancers

M. Yarchoan

Multidisciplinary Approach to Hepatobiliary Malignancies: A Changing…

UChicago Medicine

A. A. Pillai

Precision Medicine and IO Have Arrived for Cholangiocarcinoma: An Ov…

Penn Medicine Abramson Cancer Center

T. Karasic

ESMO GI 2024 Insights: Durvalumab + Chemo in Biliary Tract Cancer - …

Insights from 2024 ESMO GI Annual Meeting

D. Oh

AACR 2023 on KEYNOTE-966 Phase 3 Study: Pembro in Combination With G…

AACR 2023 Conference Coverage

K. Kelley

Cholangiocarcinoma Updates

Houston Methodist

M. Javle